• Home
  • |
  • EuroPCR 2012

EuroPCR 2012

Next edition: 21st-24th May 2013, Paris

EuroPCR2013-prelimprog

Download the programme update. (Valid as of 15 March 2013)

Registration is now open - Click here!

2012 Edition:

Access to interviews with the 2012 EuroPCR Award winners!

Access the Faculty Disclosure Summary here, updated on 7th May, 2012.

EuroPCR Editorial Board, Declarations of Interest available here

Filter by

Advanced search

[20] Myocardial infarction

Main arena
From late breaking trials to clinical practice 15:00 - 17:25
Room 241
All you need to know about FFR and intracoronary testing 15:30 - 16:50
All you need to know about TAVI 17:00 - 18:20
Room 242A
Chronic total occlusions: pathophysiology and prognosis
undefined 		12:30 - 13:50
Room 251
What support is best for patients with PCI-related calamities?
With an unrestricted educational grant from MAQUET Cardiovascular GETINGE GROUP 		12:30 - 14:00
Focus on drugs and devices used during PCI 17:00 - 18:20
Room 252AB
FAME-Trials family: physiology, decision-making and clinical outcomes
With an unrestricted educational grant from ST. JUDE MEDICAL 		17:00 - 18:30
Room 341
Renal dysfunction: impact on TAVI outcomes
undefined 		12:30 - 13:50
Room 342B
Use of transradial approach for primary PCI 12:30 - 13:50
Comparison of outcomes between DES (Part I) 15:30 - 16:50
Outcomes with new bioresorbable polymer DES 17:00 - 18:30
Room 343
Improving outcomes in primary PCI 14:00 - 15:20
DES in challenging clinical situations 17:00 - 18:30
Room 353
TAVI: patient selection and risk stratification 17:00 - 18:30
Room Maillot
Effective thrombin inhibition in high-risk ACS
With an unrestricted educational grant from THE MEDICINES COMPANY 		15:30 - 17:00
Theatre Bleu
Complication Forum - Part I
Session comprising selected EuroPCR 2012 clinical case submissions 		17:00 - 18:30
Theatre Bordeaux
Emerging clinical tools for coronary imaging and physiological lesion assessment 12:30 - 14:50
Advances in structural heart procedures: left atrial appendage closure and future transcatheter valve replacement technologies
With an unrestricted educational grant from BOSTON SCIENTIFIC 		15:00 - 17:00
Frontiers in interventional cardiology: traversing the therapeutic landscape in ACS
EBAC accredited educational programme - Programme supported by an unrestricted educational grant from ASTRAZENECA 		17:00 - 18:30
Theatre Havane
Provisional treatment approach of a Medina 1,1,1 bifurcation lesion, when and how to treat the side branch?
With an unrestricted educational grant from MINVASYS 		17:00 - 18:30

[14] Myocardial infarction

Main arena
Left main and bifurcation stenting
With an unrestricted educational grant from TERUMO and GENERAL ELECTRIC 		11:30 - 13:30
Room 241
All you need to know about adjunctive antithrombotic pharmacotherapy for PCI 15:00 - 16:20
Room 242A
Role of cardiac magnetic resonance imaging for the interventional cardiologist
With the collaboration of the ESC Working Group on Cardiovascular Magnetic Resonance 		13:40 - 15:00
Room 243
How to manage high thrombus burden in acute myocardial infarction
Under the auspices of the Working Group on Interventional Cardiology (GTCI) of the Tunisian Society of Cardiology and CardioVascular Surgery and the Working Group on Interventional Cardiology of the Netherlands Society of Cardiology 		09:00 - 10:20
Towards a standard definition of cardiovascular events: the world according to Academic Research Consortium. A case-oriented discussion 13:40 - 15:00
Room 251
New antiplatelet and antithrombotic agents in practice 16:30 - 17:50
Room 252AB
When is it safe to discontinue dual antiplatelet therapy after DES: what is the evidence and the potential impact of emerging technology?
With an unrestricted educational grant from BOSTON SCIENTIFIC 		16:30 - 18:00
Room 342B
Special issues in left main treatment
Under the auspices of the Working Group on Interventional Cardiology of the Lebanese Society of Cardiology and the Working Group on Percutaneous Coronary Interventions of the Danish Society of Cardiology 		15:00 - 16:20
Room 353
Carotid artery disease: from histology to carotid angioplasty 09:00 - 10:20
Vascular access complications using big sheaths: prevention and management 12:00 - 13:30
ESC Guidelines on diagnosis and treatment of peripheral arterial disease: a case-based discussion 16:30 - 17:50
Room Maillot
Secondary revascularisation Part I - Stent failure: understanding a multifactorial clinical problem 08:00 - 11:50
Theatre Bordeaux
Management of a patient with complex coronary artery bifurcation lesion 08:00 - 11:00
Management by PCI of a patient presenting with high-risk NSTE-ACS 14:10 - 17:10

[22] Myocardial infarction

Main arena
Hot Line from ACC 2012 - Evolving device strategies
With the collaboration of the American College of Cardiology 		10:30 - 12:00
PCR Training Centre
Coronary imaging: clinical and pathologic correlates. Lessons for interventional therapies 08:00 - 09:20
Room 241
Cardiovascular Innovation Pipeline - Drug-eluting stents 10:30 - 11:50
ACC@EuroPCR - Vulnerable lesions and patients 13:40 - 15:00
Room 242B
Left main PCI: improved outcomes through technical optimisation 08:00 - 09:00
Comparison of outcomes between DES (Part II) 10:30 - 11:50
Thrombus management during PCI 16:30 - 18:00
Room 243
TAVI registries 12:00 - 13:30
Room 251
Day-to-day teamwork in the cathlab 09:00 - 10:20
Working in the cathlab: European perspectives 10:30 - 12:10
Room 253
Results of PCI for the treatment of saphenous vein graft lesions 08:00 - 09:00
Late stent malapposition
Under the auspices of the Working Group on Percutaneous Coronary Interventions of the Danish Society of Cardiology and the Working Group on Interventional Cardiology of the Finnish Society of Cardiology 		13:40 - 15:00
Complications related to TAVI procedures
Under the auspices of the South African Society of Cardiovascular Intervention (SASCI) and the Association on Cardiovascular Interventions (ACVI) of the Polish Cardiac Society 		15:00 - 16:20
Room 341
Dedicated stents for the treatment of bifurcation lesions 10:30 - 11:50
Drug-eluting balloons: for which patients, for which coronary lesions? 15:00 - 16:20
Stent thrombosis 16:30 - 18:00
Room 342B
Decision-making process in difficult clinical situations
Under the auspices of the Working Group on Interventional Cardiology of the Hungarian Society of Cardiology, the Working Group on Interventional Cardiology of the Croatian Society of Cardiology, the Working Group on Interventional Cardiology of the Hellenic Cardiological Society, the Working Group on Interventional Cardiology of the Serbian Society of Cardiology and the Working Group on Interventional Cardiology of the Cyprus Society of Cardiology 		13:40 - 16:20
Room 351
Longitudinal deformation of coronary stents 08:00 - 09:00
Interventional cardiovascular medicine in Asia : current approaches and challenges
With an unrestricted educational grant from MEDTRONIC 		16:30 - 18:00
Room Maillot
Emerging technologies for coronary imaging and lesion assessment 08:20 - 11:20
Theatre Bleu
Interventional treatment of coronary chronic total occlusion: 2012 update
With the collaboration of Complex Cardiovascular Therapeutics (CCT) 		08:00 - 11:20
Theatre Bordeaux
Management by PCI of a patient presenting with STEMI 08:00 - 11:00

[10] Myocardial infarction

Room 242A
ACS in specific patient subsets 10:30 - 11:20
Room 242B
Cardiogenic shock in STEMI patients 10:30 - 11:20
Room 243
Treatment of in-stent restenosis 11:30 - 12:50
Room 251
Trials, registries and late breaking science 09:00 - 10:20
Room 253
New strategies for antithrombotic therapy during coronary interventions 09:00 - 10:20
Antiplatelet therapy for coronary interventions: any help from platelet testing and/or genotyping? 11:30 - 12:50
Room 342B
IVUS-guided interventions 10:30 - 11:20
Clinical evaluation of bioresorbable vascular scaffolds 11:30 - 12:50
Room 343
Chronic total occlusions: procedural aspects 11:30 - 12:50
Room 353
Advanced management of carotid stenting: a case-based discussion
undefined 		09:00 - 10:30